Search - tctmd.com

Displaying 381 - 400 of 655

Sort: Relevancy | Date

Cardiac Rehab During COVID-19: Telehealth, Unpaid Heroes Step Up to Help at Home

News Features

Cardiac Rehab During COVID-19: Telehealth, Unpaid Heroes Step Up to Help at Home

April 10, 2020

ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up

News Conference News ACC 2020

ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up

March 30, 2020

Telehealth Offers a Lifeline for Cardiology Patients During the COVID-19 Pandemic

News Features

Telehealth Offers a Lifeline for Cardiology Patients During the COVID-19 Pandemic

Yael L. Maxwell

March 24, 2020

News Daily News

COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say

March 17, 2020

AHA: Advice on Lifestyle, Risk Factor Modification to Cut A-fib Events

News Daily News

AHA: Advice on Lifestyle, Risk Factor Modification to Cut A-fib Events

Yael L. Maxwell

March 13, 2020

TCTMD’s Top 10 Most Popular Stories for February 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2020

March 02, 2020

Industry Payments to Vascular Neurologists Jump in the Thrombectomy Era

News Conference News ISC 2020

Industry Payments to Vascular Neurologists Jump in the Thrombectomy Era

February 29, 2020

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

News Daily News

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

Michael O'Riordan

January 16, 2020

New AUC for Cardiac Imaging Follow-up in Congenital Heart Disease

News Daily News

New AUC for Cardiac Imaging Follow-up in Congenital Heart Disease

Michael O'Riordan

January 10, 2020

AHA Plugs ‘Dietary Patterns’ Over Dietary Cholesterol Targets

News Daily News

AHA Plugs ‘Dietary Patterns’ Over Dietary Cholesterol Targets

Yael L. Maxwell

December 26, 2019

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

News Daily News

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Yael L. Maxwell

December 20, 2019

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

December 10, 2019

TCTMD’s Top 10 Most Popular Stories for November 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2019

November 29, 2019

Uninformed Consent? Most Patients Misunderstand True Benefits of PCI

News Daily News

Uninformed Consent? Most Patients Misunderstand True Benefits of PCI

Michael O'Riordan

November 29, 2019

Some A-fib Patients May Need a Bit More Aspirin After PCI: AUGUSTUS

News Conference News AHA 2019

Some A-fib Patients May Need a Bit More Aspirin After PCI: AUGUSTUS

November 20, 2019

Early Data Favorable for New RNAi Therapies to Reduce Triglycerides

News Conference News AHA 2019

Early Data Favorable for New RNAi Therapies to Reduce Triglycerides

November 19, 2019

Inclisiran in FH: Safe, Cuts LDL in This Challenging Group

News Conference News AHA 2019

Inclisiran in FH: Safe, Cuts LDL in This Challenging Group

Yael L. Maxwell

November 19, 2019

EVAPORATE Hints at Slowed Plaque Progression With Icosapent Ethyl

News Conference News AHA 2019

EVAPORATE Hints at Slowed Plaque Progression With Icosapent Ethyl

November 18, 2019

Effect of Icosapent Ethyl on progression of coronary atherosclerosis in patients with elevated triglycerideson statin therapy: the EVAPORATE study

Presentation AHA 2019

Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides on Statin Therapy: The EVAPORATE Study

Presenter: Matthew Budoff

November 18, 2019

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

News Conference News AHA 2019

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

November 17, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.